Insights on personalized medicine from ayurveda

Journal of Alternative and Complementary Medicine

Volumn 19, Issue 4, 2013, Pages 370-375

  Sumantran, Venil N ^a   Tillu, Girish ^b  

^a INDIAN INSTITUTE OF TECHNOLOGY MADRAS   (India)

^b SYMBIOSIS INTERNATIONAL UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; AYURVEDA; CHINESE MEDICINE; CLINICAL ASSESSMENT; DISEASE PREDISPOSITION; DRUG INDUSTRY; HUMAN; KOREAN MEDICINE; MAJOR HISTOCOMPATIBILITY COMPLEX; PERSONALIZED MEDICINE; PRIORITY JOURNAL;

DIAGNOSIS, DIFFERENTIAL; DISEASE SUSCEPTIBILITY; HUMANS; INDIVIDUALIZED MEDICINE; MEDICINE, AYURVEDIC; MEDICINE, CHINESE TRADITIONAL; MEDICINE, KOREAN TRADITIONAL; MOLECULAR MEDICINE;

EID: 84876368890     PISSN: 10755535     EISSN: 15577708     Source Type: Journal    
DOI: 10.1089/acm.2011.0698     Document Type: Article

References (55)

1. Sharma HM. Contemporary Ayurveda. In: MS Micozzi, ed. Fundamentals of Complementary and Alternative Medicine, 4th ed. St. Louis, MO: Saunders Elsevier; 2011:495-508.
2. Sharma PV. Charaka Samhita (English translation). Varanasi, India: Chaukhamba Orientalia; 2000.
3. Svoboda RE. Ayurveda: Life Health and Longevity. Delhi, India: Penguin Books India Ltd.; 1992:51-57.
4. Valiathan MS. The Legacy of Caraka. Orient Longman; 2003.
5. Prasher B, Negi S, Aggarwal S, et al. Whole genome expression and biochemical correlates of extreme constitutional types defined in Ayurveda. J Transl Med 2008;6:48-60.
6. Paradkar H. Ashtang Hridayam (Reprint). Varanasi, India: Chaukhambha Sanskrit Series; 2000:39-50.
7. Acharya YT. Charaka Samhita (Reprint). Varanasi, India: Chaukhamba Surbharati; 2000:256.
8. Acharya YT. Charaka Samhita (Reprint). Varanasi, India: Chaukhamba Surbharati; 2000:105.
9. Paradkar H. Ashtang Hridayam (Reprint). Varanasi, India: Chaukhambha Sanskrit Series; 2000:14.
10. Patwardhan B, Warude D, Pushpangadan P, Bhatt N. Ayurveda and Traditional Chinese Medicine: A comparative overview. Evid Based Complement Alternat Med 2005;2: 465-473. (Pubitemid 41752482)
11. Lu A, Jiang M, Zhang C, Chan K. An integrative approach of linking traditional Chinese medicine pattern classification and biomedicine diagnosis. J Ethnopharmacol 2012;141: 549-556.
12. Lu C, Zha Q, Chang A, He Y, Lu A. Pattern differentiation in Traditional Chinese Medicine can help define specific indications for biomedical therapy in the treatment of rheumatoid arthritis. J Altern Complement Med 2009;15:1021-1025.
13. Lu AP, Chen KJ. Chinese medicine pattern diagnosis could lead to innovation in medical sciences. Chin J Integr Med 2011;17:811-817.
14. Kim BY, Cha S, Jin HJ, Jeong S. Genetic approach to elucidation of sasang constitutional medicine. Evid Based Complement Alternat Med 2009;Suppl 1:51-57.
15. Lee TG, Koh B, Lee S. Sasang constitution as a risk factor for diabetes mellitus: A cross-sectional study. Evid Based Complement Alternat Med 2009;1:99-103.
16. Lee J, Lee J, Lee E, Yoo J, Kim Y, Koh B. The Sasang constitutional types can act as a risk factor for hypertension. Clin Exp Hypertens 2011;33:525-532.
17. Rao AV. Mind in Ayurveda. Indian J Psychiatry 2002;3: 201-211.
18. Patwardhan B. Ayurveda: The designer medicine. Indian Drugs 2000;37:213-227.
19. Patwardhan B, Joshi K, Chopra A. Classification of human population based on HLA gene polymorphism and the concept of Prakriti in Ayurveda. J Altern Complement Med 2005;11:349-353.
20. Patwardhan B, Joshi, Ghodke Y. Genetic basis to concept of Prakriti. Curr Sci 2006;90(07):896.
21. Patwardhan B, Bodeker G. Ayurvedic genomics: Establishing a genetic basis for mind-body typologies. J Altern Complement Med 2008:571-576. (Pubitemid 351873380)
22. Chen S, Lv F, Gao J, et al. HLA class II polymorphisms associated with the physiologic characteristics defined by Traditional Chinese Medicine: Linking modern genetics with an ancient medicine. J Altern Complement Med 2007;13: 231-239. (Pubitemid 46516708)
23. Thorsby E, Lie BA. HLA associated genetic predisposition to autoimmune diseases: Genes involved and possible mechanisms. Transp Immunol 2005;(3-4):175-182. (Pubitemid 40848523)
24. de Bakker PI, McVean G, Sabeti PC, et al. A high-resolution HLA and SNP haplotype map for disease association studies in the extended human MHC. Nat Genet 2006;38:1166-1172. (Pubitemid 44470362)
25. Fiorillo MT, Greco G, Maragno M, et al. The naturally occurring polymorphism Asp116- > His116, differentiating the ankylosing spondylitis-associated HLA-B&z.ast;2705 from the non-associated HLA-B&z.ast;2709 subtype, influences peptidespecific CD8 T cell recognition. Eur J Immunol 1998;8: 2508-2516. (Pubitemid 28362725)
26. Cassinotti A, Birindelli S, Clerici M, et al. HLA and autoimmune digestive disease: A clinically oriented review for gastroenterologists. Am J Gastroenterol 2009;104:195-217.
27. Caillat-Zucman S. Molecular mechanisms of HLA association with autoimmune diseases. Tissue Antigens 2009; 73:1-8.
28. Gorodezky C, Alaez C, Murguía A, et al. HLA and autoimmune diseases: Type 1 diabetes (T1D) as an example. Autoimmun Rev 2006;3:187-194. (Pubitemid 43234183)
29. Ku CS, Loy EY, Pawitan Y, Chia KS. The pursuit of genomewide association studies: Where are we now? J Hum Genet 2010;55:195-206.
30. Yang C, Zhou X, Wan X, Yang Q, Xue H, Yu W. Identifying disease-associated SNP clusters via contiguous outlier detection. Bioinformatics 2011;27:2578-2585.
31. Petsko GA. Comment: Guilt by association. Genome Biol 2009;10:104-107.
32. Vineis P, E Pearce N. Genome-wide association studies may be misinterpreted: Genes versus heritability. Carcinogenesis 2011;32:1295-1298.
33. Eleftherohorinou H, Wright V, Hoggart C, et al. Pathway analysis of GWAS provides new insights into genetic susceptibility to 3 inflammatory diseases. PLoS One 2009;4(11):e8068.
34. Menon R, Farina C. Shared molecular and functional frameworks among five complex human disorders: A comparative study on interactomes linked to susceptibility genes. PLoS One. 2011;6:e18660.
35. Paradkar H. Ashtang Hridayam (Reprint). Varanasi, India: Chaukhambha Sanskrit Series; 2000:201.
36. Paradkar H. Ashtang Hridayam (Reprint). Varanasi, India: Chaukhambha Sanskrit Series; 2000:201-202.
37. Hirsch HA, Iliopoulos D, Joshi A, et al. A transcriptional signature and common gene networks link cancer with lipid metabolism and diverse human diseases. Cancer Cell 2010;17:348-361.
38. Kreeft AJ, Moen CJ, Porter G, et al. Genomic analysis of the response of mouse models to high-fat feeding shows a major role of nuclear receptors in the simultaneous regulation of lipid and inflammatory genes. Atherosclerosis 2005;182: 249-257. (Pubitemid 41267192)
39. Sharma H, Chandola HM. Ayurvedic concept of obesity, metabolic syndrome, and diabetes mellitus. J Altern Complement Med 2011;17:549-552.
40. Tipton CM. Susruta of India, an unrecognized contributor to the history of exercise physiology. J Appl Physiol 2008;104: 1553-1556.
41. Lin JD. The PGC-1 coactivator networks: Chromatinremodeling and mitochondrial energy metabolism. Minireview. Mol Endocrinol 2009;23:2-10.
42. Loktionov A. Common gene polymorphisms and nutrition: Emerging links with pathogenesis of multifactorial chronic diseases. Review. J Nutr Biochem 2003;14:426-451. (Pubitemid 37020963)
43. Joober J. The 1000 Genomes Project: Deep genomic sequencing waiting for deep psychiatric phenotyping. J Psychiatry Neurosci 2011;36:147-149.
44. Rivas MA, Beaudoin M, Gardet A, et al. Deep resequencing of GWAS loci identifies independent rare variants associated with inflammatory bowel disease. Nat Genet 2011;43: 1066-1073.
45. Hegele RA, Reue K. Hoofbeats, zebras, and insights into insulin resistance. J Clin Invest 2009;119:249-251.
46. Tracy RP. 'Deep phenotyping': Characterizing populations in the era of genomics and systems biology. Curr Opin Lipidol 2008;19:151-157. (Pubitemid 351483302)
47. Zhou SF, Liu JP, Chowbay B. Polymorphism of human cytochrome P450 enzymes and its clinical impact. Drug Metab Rev 2009;41:89-95.
48. Ghodke Y, Joshi K, Patwardhan B. Traditional medicine to modern pharmacogenomics: Ayurveda prakriti type and CYP2C19 gene polymorphism associated with the metabolic variability. Evid Based Complement Alternat Med. 2011; Epub 2011 Jun 8. doi:10.1093/ecam/nep206.
49. Joshi K, Ghodke Y, Shintre P. Traditional medicine and genomics. J Ayurveda Integr Med 2010;1:26-32.
50. Paradkar H. Ashtang Hridayam (Reprint). Varanasi, India: Chaukhambha Sanskrit Series; 2000:207-208.
51. Paradkar H. Ashtang Hridayam (Reprint). Varanasi, India: Chaukhambha Sanskrit Series; 2000:207.
52. Rezzi S, Ramadan Z, Fay LB, Kochhar S. Nutritional metabonomics: Applications and perspectives. J Proteome Res 2007;6:513-525. (Pubitemid 46340155)
53. Kroemer HK, Meyer zu Schwabedissen HE. A piece in the puzzle of personalized medicine. Review. Clin Pharmacol Ther 2010;87:19-20.
54. Nebert DW, Zhang G, Vesell ES. From human genetics and genomics to pharmacogenetics and pharmacogenomics: Past lessons, future directions. Drug Metab Rev 2008;40:187-224. (Pubitemid 352000946)
55. Sumantran VN, Tillu G. Ayurvedic pharmaceutics and insights on personalized medicine. In: VK Gupta, ed. Progress in Traditional and Folk Herbal Medicine, Delhi: Daya Publishing House, 2011; vol. 1. chapter 2: 13-52.